Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib with Platinum-Pemetrexed in Mesothelioma
NCT01590160Phase 2Completed
- Sponsor
- University College London
- Start
- Aug 2013
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in malignant pleural mesothelioma (MPM), sponsored by University College London. Started Aug 2013; status: completed.
02
Drugs
ganetespib
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01590160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01590160.